1. Home
  2. Amity University confers honorary doctorate on Thumbay Moideen

Amity University confers honorary doctorate on Thumbay Moideen

coastaldigest.com news network
November 21, 2017

Dubai, Nov 21: Thumbay Moideen, the Founder President of Dubai-based global conglomerate Thumbay Group, was conferred an Honorary Doctorate at the annual convocation ceremony of Amity University – Dubai, on November 20. Mr. Moideen, the Guest of Honour of the convocation ceremony, was awarded the doctorate in the presence of distinguished dignitaries, academicians, students, teachers and parents.

An official statement by Amity University Dubai said that Mr.ThumbayMoideen was being conferred the honor in view of his “significant contributions towards promotion of medical education, trade and industry, and social and economic development of the nation.”

In his acceptance speech, Mr. Thumbay Moideen expressed his gratitude to Amity University Dubai for awardingthe doctorate. “Throughout my career, I have had the privilege of transforming lives through education and healthcare, strengthening communities and contributing to the growth and progress of the nation. I owe my success to God Almighty, the support of the government, and my team. This recognition will inspire me to do more in driving positive change,” he said.

Mr. Thumbay Moideen awarded certificates to the graduates and the honors for batch toppers.

About Mr. Thumbay Moideen

Mr. ThumbayMoideen is the Founder President of Thumbay Group, a diversified international conglomerate headquartered at DIFC - Dubai, United Arab Emirates (UAE). Starting with the establishment of Thumbay Group in 1998, he has set up business operations in 20 sectors. Today, the Group has activities in Education, Healthcare, Medical Research, Diagnostics, Retail Pharmacy, Health Communications, Retail Optical, Wellness, Nutrition Stores, Hospitality, Real Estate, Publishing, Technology, Media, Events, Medical Tourism, Trading and Marketing & Distribution.

Thumbay Group today employs close to 5000 people, which is projected to increase to around 25000 by the year 2022, with the completion of ongoing and upcoming projects. The Thumbay chain of hospitals, the constituent teaching hospitals of the Gulf Medical University are one of the largest healthcare services providers in the UAE, serving patients from over 175 nationalities. The Gulf Medical University (GMU) which is one of the leading private medical universities in the Middle East region, attracts a student cohort of 80 nationalities and faculty and staff from over 25 countries. Currently, Thumbay Group is focusing on its strategic long-term plans which will see the group scale its businesses almost ten times and expand its operations globally.

The Group plans to build three more international campuses in the next five years. This is in addition to the plans to expand the chain of academic hospitals to 15 worldwide by 2022, with a total capacity of 1000 beds in the UAE, 1500 beds in India and 750 beds elsewhere in the Gulf and in Africa. The group also plans to expand specialized retail outlets.

Comments

ABDUL SALAM BELMA
 - 
Wednesday, 22 Nov 2017

All the best, congrats to well deserved person

Ahmed Bava
 - 
Tuesday, 21 Nov 2017

Masha Allah Mabrook Mr.Moideen Thumbay

AR Shetty
 - 
Tuesday, 21 Nov 2017

Hearty Congratulations saab

Muhammed Ali Uchil
 - 
Tuesday, 21 Nov 2017

Great honor-A Doctorate from World reputed Amity University-

thanks for  choosing the  right and most deserved person for 

this Privilege .

 

Heartily Congratulations Moideen Saab.

Danish
 - 
Tuesday, 21 Nov 2017

Wow. great! All the best for your future ventures..

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 17,2020

Udupi, May 17: A total of 1,460 migrant labourers left for Uttar Pradesh from Indrali Railway Station in Udupi in Shramik Special train on Sunday.

This is the first train to ferry migrant labourers from Udupi. As many as 236 from Karkala, 323 from Kundapura, 901 labourers from Brahmavar, Kaup and Udupi left for their native villages.

More than 2,000 labourers had gathered at the railway station and only 1,460 labourers received tickets to travel.

Those who did not receive tickets were disappointed and got into heated arguments with the officials.

The labourers were promised that they will receive tickets to another train, that would depart from Udupi before May 20. One bogie of the train was reserved for pregnant women, women and children.

As many as 1,712 from Jharkhand, 770 from Odisha, 977 from West Bengal, 1,600 from Bihar, 379 from Madhya Pradesh, 280 from Chattisgarh, 110 from Uttarkhand, 379 from Rajasthan had registered on Seva Sindhu portal.

Additional Deputy Commissioner B Sadashiva Prabhu said that there are plans to make arrangements to send migrant labourers from UP, Uttaranchal, Madhya Pradesh and Jharkhand.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 17,2020

Bengaluru, July 17: A 60-year-old woman who tested positive for Covid-19 allegedly ended her life in the Covid ward at KC General Hospital in the early hours of Friday.

The woman, the fourth Covid positive patient to end her life since April, was a resident of Mariyappanapalya near Jnanabharathi in West Bengaluru. She was found hanging from a window grille in the passage of the Covid ward around 5 am. She had used her sari to hang herself.

The police said that the woman was admitted to the hospital on July 1. She was responding well to the treatment and was almost cured. Her son was infected first and admitted to the same hospital. As she later tested positive and got admitted, her son was discharged on July 11. The police suspect that the woman may have resorted to the extreme step due to depression.

An investigating officer quoted doctors telling the police that they were about to inform the woman about her discharge date on Friday. Doctors were waiting for the report on her latest test before discharging her.

The woman’s body will be subjected to an autopsy as per the Covid standard procedure. The Malleswaram police have taken up a case of unnatural death. Investigations are on. 

On July 11, a 70-year-old man ended his life in the toilet of the Covid ward in Victoria Hospital, while a suicide was reported in the same ward on June 26. A 60-year-old woman also hanged herself in the toilet. Her son, daughter-in-law, and grandson were also admitted to hospital for Covid-19.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.